Cite
Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, Synthesis, and Antimalarial Activity
MLA
Thomas Tremblay, et al. “Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, Synthesis, and Antimalarial Activity.” ACS Medicinal Chemistry Letters, vol. 14, Jan. 2023, pp. 217–22. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dd76e3531e0847e45a0037eaaef9222c&authtype=sso&custid=ns315887.
APA
Thomas Tremblay, Catherine Bergeron, Dominic Gagnon, Christopher Bérubé, Normand Voyer, Dave Richard, & Denis Giguère. (2023). Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, Synthesis, and Antimalarial Activity. ACS Medicinal Chemistry Letters, 14, 217–222.
Chicago
Thomas Tremblay, Catherine Bergeron, Dominic Gagnon, Christopher Bérubé, Normand Voyer, Dave Richard, and Denis Giguère. 2023. “Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, Synthesis, and Antimalarial Activity.” ACS Medicinal Chemistry Letters 14 (January): 217–22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dd76e3531e0847e45a0037eaaef9222c&authtype=sso&custid=ns315887.